Breast tumors clearly express phosphorylated PR molecules (Fig. 1e and 2a) predicted to be deSUMOylated and transcriptionally hyperactive at a subset of SUMO-sensitive and phosphorylation-dependent gene promoters [32]. This evidence concerns the gene PGR and breast neoplasm.